EQRX INC(NASDAQ:EQRX) stock Fundamental Analysis

Fundamental Rating

Taking everything into account, EQRX scores 3 out of 10 in our fundamental rating. EQRX was compared to 571 industry peers in the Biotechnology industry. While EQRX has a great health rating, there are worries on its profitability. EQRX does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year EQRX has reported negative net income.

EQRX had a negative operating cash flow in the past year.

1.2 Ratios

With an excellent Return On Assets value of -20.04%, EQRX belongs to the best of the industry, outperforming 81.92% of the companies in the same industry.

The Return On Equity of EQRX (-21.05%) is better than 85.07% of its industry peers.

		Industry Rank	Sector Rank
ROA	-20.04%
ROE	-21.05%
ROIC	N/A

ROA(3y)-22.45%

ROA(5y)N/A

ROE(3y)-23.54%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EQRX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, EQRX has more shares outstanding

There is no outstanding debt for EQRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

EQRX has an Altman-Z score of 11.47. This indicates that EQRX is financially healthy and has little risk of bankruptcy at the moment.

With an excellent Altman-Z score value of 11.47, EQRX belongs to the best of the industry, outperforming 91.54% of the companies in the same industry.

There is no outstanding debt for EQRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	11.47

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 22.60 indicates that EQRX has no problem at all paying its short term obligations.

Looking at the Current ratio, with a value of 22.60, EQRX belongs to the top of the industry, outperforming 96.02% of the companies in the same industry.

A Quick Ratio of 22.60 indicates that EQRX has no problem at all paying its short term obligations.

With an excellent Quick ratio value of 22.60, EQRX belongs to the best of the industry, outperforming 96.02% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	22.6
Quick Ratio	22.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for EQRX have decreased strongly by -62.64% in the last year.

EPS 1Y (TTM)-62.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%11.76%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -9.08% on average over the next years.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-92.67%

EPS Next 2Y-37.78%

EPS Next 3Y-19.35%

EPS Next 5Y-9.08%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EQRX. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EQRX. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

EQRX's earnings are expected to decrease with -19.35% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-37.78%

EPS Next 3Y-19.35%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

EQRX does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EQRX INC

NASDAQ:EQRX (11/8/2023, 8:00:02 PM)

After market: 2.39 +0.05 (+2.14%)

2.34

-0.05 (-2.09%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)11-09 2023-11-09/amc

Earnings (Next)N/A N/A

Inst Owners3.06%

Inst Owner Change0%

Ins Owners0.52%

Ins Owner Change0%

Market Cap1.26B

Analysts42.86

Price Target2.14 (-8.55%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-12.13%

Min EPS beat(2)-15.79%

Max EPS beat(2)-8.46%

EPS beat(4)2

Avg EPS beat(4)16.22%

Min EPS beat(4)-15.79%

Max EPS beat(4)75.91%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-17.65%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-15.11%

EPS NY rev (1m)0%

EPS NY rev (3m)-15.71%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	1.01
P/tB	1.01
EV/EBITDA	N/A

EPS(TTM)-0.55

EYN/A

EPS(NY)-0.68

Fwd EYN/A

FCF(TTM)-0.62

FCFYN/A

OCF(TTM)-0.61

OCFYN/A

SpS0

BVpS2.32

TBVpS2.32

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-20.04%
ROE	-21.05%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-22.45%

ROA(5y)N/A

ROE(3y)-23.54%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	203.78%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	22.6
Quick Ratio	22.6
Altman-Z	11.47

F-Score3

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)346.9%

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-62.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%11.76%

EPS Next Y-92.67%

EPS Next 2Y-37.78%

EPS Next 3Y-19.35%

EPS Next 5Y-9.08%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y1.88%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-11.34%

EBIT Next 3Y2.85%

EBIT Next 5Y0.08%

FCF growth 1Y-57.06%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-56.82%

OCF growth 3YN/A

OCF growth 5YN/A

EQRX INC (EQRX) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens